BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 8133137)

  • 1. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
    Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An analysis of pelvic and para-aortic lymph node metastasis in ovarian carcinoma by systematic retroperitoneal lymph node dissection].
    Tsumura N; Sakuragi N; Hareyama H; Nomura E; Ohkouchi T; Yamamoto R; Takeda N; Nishiya M; Hirahatake K; Fujino T; Okubo H; Satoh C; Makinoda S; Kawaguchi I; Fujimoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):508-14. PubMed ID: 8754392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
    Yavuzcan A; Baloglu A; Cetinkaya B
    Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-pathologic evaluation of retroperitoneal lymph node metastasis in ovarian carcinoma].
    Takahashi Y; Chiba T; Inaba S; Yamamoto A; Nomura T; Yamamoto Y; Kasahara K; Tenzaki T; Ishiguro T; Yoshida Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1489-94. PubMed ID: 2273303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
    Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroperitoneal lymph node metastasis in patients with ovarian cancer].
    Kasamatsu T; Yoshikawa H; Yokota H; Kume M; Kuwabara Y; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):473-8. PubMed ID: 2746072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retroperitoneal lymph node metastasis in epithelial cancer of the ovary: a report of 58 cases].
    Xie R; Lin YZ; Chen GL
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):499-501. PubMed ID: 15555344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
    Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
    Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study on the incidence of retroperitoneal lymph node metastasis and its risk factors in ovarian cancer].
    Wu X; Zhang Z; Tang M
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):543-7. PubMed ID: 9275427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastasis in stage I ovarian carcinoma.
    Lang JH
    Chin Med J (Engl); 1994 Sep; 107(9):643-7. PubMed ID: 7805453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymph node metastasis in stage I ovarian cancer].
    Jang JH
    Zhonghua Fu Chan Ke Za Zhi; 1992 Nov; 27(6):338-40, 379. PubMed ID: 1300277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Gynecol Oncol; 2005 Apr; 97(1):136-41. PubMed ID: 15790449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.